Esperion Therapeutics
ESPR
#7312
Rank
โ‚น46.58 B
Marketcap
โ‚น180.99
Share price
0.52%
Change (1 day)
149.82%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: โ‚น46.58 Billion

As of April 2026 Esperion Therapeutics has a market cap of โ‚น46.58 Billion. This makes Esperion Therapeutics the world's 7312th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น46.58 B-45.82%
2025โ‚น85.97 B123.09%
2024โ‚น38.53 B36.15%
2023โ‚น28.30 B-25.48%
2022โ‚น37.98 B67.6%
2021โ‚น22.66 B-54.01%
2020โ‚น49.27 B-57.86%
2019โ‚น116.92 B35.52%
2018โ‚น86.28 B-21.66%
2017โ‚น110.13 B473.95%
2016โ‚น19.18 B-42.39%
2015โ‚น33.30 B-36.12%
2014โ‚น52.14 B300.4%
2013โ‚น13.02 B

End of Day market cap according to different sources

On Apr 21st, 2026 the market cap of Esperion Therapeutics was reported to be:

โ‚น46.34 Billion
by Nasdaq info icon info icon
โ‚น46.34 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น14.277 T 30,546.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น7.386 T 15,755.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น226.98 B 387.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น73.10 B 56.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น425.92 B 814.27%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น973.89 B 1,990.51%๐Ÿ‡บ๐Ÿ‡ธ USA